Free Trial

OptiBiotix Health (OPTI) Competitors

OptiBiotix Health logo
GBX 17.75 -1.50 (-7.79%)
(As of 12/20/2024 12:19 PM ET)

OPTI vs. KOD, ORPH, AMPH, ANW, AURA, MRK, PHE, REVB, CYAN, and OKYO

Should you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include Kodal Minerals (KOD), Open Orphan (ORPH), Aggregated Micro Power (AMPH), Aberdeen New Thai Investment Trust (ANW), Aura Energy (AURA), Marks Electrical Group (MRK), PowerHouse Energy Group (PHE), Revolution Beauty Group (REVB), CyanConnode (CYAN), and OKYO Pharma (OKYO). These companies are all part of the "pharmaceutical products" industry.

OptiBiotix Health vs.

OptiBiotix Health (LON:OPTI) and Kodal Minerals (LON:KOD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Kodal Minerals' return on equity of 75.19% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OptiBiotix HealthN/A -36.34% -13.93%
Kodal Minerals N/A 75.19%-5.71%

OptiBiotix Health has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500. Comparatively, Kodal Minerals has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500.

In the previous week, Kodal Minerals had 2 more articles in the media than OptiBiotix Health. MarketBeat recorded 2 mentions for Kodal Minerals and 0 mentions for OptiBiotix Health. Kodal Minerals' average media sentiment score of 0.45 beat OptiBiotix Health's score of 0.00 indicating that Kodal Minerals is being referred to more favorably in the news media.

Company Overall Sentiment
OptiBiotix Health Neutral
Kodal Minerals Neutral

Kodal Minerals has lower revenue, but higher earnings than OptiBiotix Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OptiBiotix Health£1.26M13.80-£2.98M-£0.03-591.67
Kodal MineralsN/AN/A£27.19MN/AN/A

OptiBiotix Health received 32 more outperform votes than Kodal Minerals when rated by MarketBeat users. However, 62.78% of users gave Kodal Minerals an outperform vote while only 59.18% of users gave OptiBiotix Health an outperform vote.

CompanyUnderperformOutperform
OptiBiotix HealthOutperform Votes
145
59.18%
Underperform Votes
100
40.82%
Kodal MineralsOutperform Votes
113
62.78%
Underperform Votes
67
37.22%

4.9% of OptiBiotix Health shares are owned by institutional investors. Comparatively, 0.0% of Kodal Minerals shares are owned by institutional investors. 12.0% of OptiBiotix Health shares are owned by company insiders. Comparatively, 30.1% of Kodal Minerals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Kodal Minerals has a consensus price target of GBX 1.45, indicating a potential upside of 313.11%. Given Kodal Minerals' stronger consensus rating and higher possible upside, analysts clearly believe Kodal Minerals is more favorable than OptiBiotix Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptiBiotix Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Kodal Minerals
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Kodal Minerals beats OptiBiotix Health on 10 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPTI vs. The Competition

MetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON Exchange
Market Cap£17.38M£164.65M£5.14B£1.88B
Dividend YieldN/A3.64%5.09%5.54%
P/E Ratio-591.67115.5190.051,810.29
Price / Sales13.8018,239.951,117.14382,807.21
Price / Cash8.6812.7543.0428.42
Price / Book2.228.504.782.91
Net Income-£2.98M-£20.67M£120.31M£156.83M
7 Day Performance-16.27%-1.04%-1.92%-1.92%
1 Month Performance44.90%136.65%11.51%17.93%
1 Year Performance-26.89%137.57%30.61%29.50%

OptiBiotix Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPTI
OptiBiotix Health
N/AGBX 17.75
-7.8%
N/A-26.9%£17.38M£1.26M-591.671High Trading Volume
KOD
Kodal Minerals
N/AGBX 0.35
+2.9%
GBX 1.45
+310.2%
-8.8%£71.58MN/A0.0090News Coverage
Gap Down
ORPH
Open Orphan
N/AGBX 10
+5.3%
N/A+0.0%£67.09M£34.71M-25.30179
AMPH
Aggregated Micro Power
N/AN/AN/AN/A£64.54M£49.33M70.771,620Gap Up
ANW
Aberdeen New Thai Investment Trust
N/AGBX 398
-1.0%
N/A+0.0%£63.63M£2.08M120.615
AURA
Aura Energy
N/AGBX 7
-3.4%
N/A-50.2%£55.31M£92,496.00-700.0050High Trading Volume
MRK
Marks Electrical Group
1.3088 of 5 stars
GBX 52.50
flat
GBX 100
+90.5%
-42.2%£54.96M£114.26M1,613.00200News Coverage
PHE
PowerHouse Energy Group
N/AGBX 1.17
+8.3%
N/A+222.1%£49.14M£680,842.00-138.004Gap Up
REVB
Revolution Beauty Group
N/AGBX 15.02
-5.4%
N/A-55.6%£47.96M£191.29M500.8010Gap Down
CYAN
CyanConnode
N/AGBX 9.20
flat
N/A+12.7%£31.98M£18.73M-920.00100Gap Down
OKYO
OKYO Pharma
N/AGBX 1.40
-24.3%
N/AN/A£23.24MN/A-140.007News Coverage
Gap Down

Related Companies and Tools


This page (LON:OPTI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners